IOL Chemicals and Pharmaceuticals Ltd. | Small-cap | Healthcare
₹97.49
2.64%
| IOL Chemicals Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 20.8B
Gross Profit 6.9B 33.06%
Operating Income 1.3B 6.27%
Net Income 1.0B 4.86%
EPS (Diluted) ₹3.44

Balance Sheet Metrics

Total Assets 23.8B
Total Liabilities 6.9B
Shareholders Equity 16.9B
Debt to Equity 0.41

Cash Flow Metrics

Operating Cash Flow 1.7B
Free Cash Flow -349.3M

Revenue & Profitability Trend

IOL Chemicals Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 20.8B 21.2B 22.0B 21.7B 19.5B
Cost of Goods Sold 13.9B 14.2B 15.8B 16.0B 11.2B
Gross Profit 6.9B 7.0B 6.2B 5.7B 8.2B
Operating Expenses 2.7B 2.8B 2.5B 1.9B 1.4B
Operating Income 1.3B 1.7B 1.8B 2.2B 5.5B
Pre-tax Income 1.4B 1.8B 1.9B 2.2B 5.7B
Income Tax 368.9M 472.2M 495.1M 571.8M 1.3B
Net Income 1.0B 1.3B 1.4B 1.7B 4.4B
EPS (Diluted) ₹3.44 ₹22.90 ₹23.70 ₹28.56 ₹76.21

Income Statement Trend

IOL Chemicals Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 11.5B 11.2B 9.2B 10.8B 10.2B
Non-Current Assets 12.3B 11.2B 11.0B 8.8B 5.9B
Total Assets 23.8B 22.4B 20.2B 19.6B 16.1B
Liabilities
Current Liabilities 6.1B 5.6B 4.6B 5.1B 2.9B
Non-Current Liabilities 845.0M 728.9M 581.5M 564.2M 591.1M
Total Liabilities 6.9B 6.3B 5.1B 5.7B 3.5B
Equity
Total Shareholders Equity 16.9B 16.1B 15.1B 13.9B 12.6B

Balance Sheet Composition

IOL Chemicals Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 1.4B 1.8B 1.9B 2.2B 5.7B
Operating Cash Flow 1.7B 1.1B 2.3B -706.1M 4.2B
Investing Activities
Capital Expenditures -2.1B -2.7B -2.1B -1.5B -1.1B
Investing Cash Flow -1.7B -2.0B -1.4B -1.4B -3.3B
Financing Activities
Dividends Paid -234.8M -293.5M -235.0M -352.2M -234.8M
Financing Cash Flow 608.0M -762.2M 133.8M 502.8M -1.1B
Free Cash Flow -349.3M 159.1M -895.5M -602.4M 2.7B

Cash Flow Trend

IOL Chemicals Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 26.45
Forward P/E 2.37
Price to Book 1.58
Price to Sales 1.28
PEG Ratio 2.37

Profitability Ratios

Profit Margin 4.86%
Operating Margin 8.38%
Return on Equity 6.13%
Return on Assets 3.52%

Financial Health

Current Ratio 1.89
Debt to Equity 6.94
Beta 0.57

Per Share Data

EPS (TTM) ₹3.44
Book Value per Share ₹57.47
Revenue per Share ₹70.77

Financial data is updated regularly. All figures are in the company's reporting currency.